Glaucoma

Biotech News

SpyGlass Pharma IPO Raises $172.5M to Develop Implantable Eye Therapies
Biotech Blogs

National Glaucoma Awareness Month 2026: What’s New in Glaucoma Care and Research
Life Science Podcast

The Biology of Aging: Innovations in Cellular Rejuvenation with Life Biosciences’ Dr. Sharon Rosenzweig-Lipson — Episode 235
Life Science Podcast

Innovating Approaches to Target Diseases of Aging with Jerry McLaughlin, CEO of Life Biosciences
Blogs

World Glaucoma Week 2024: New Advances in Glaucoma Care
Blogs

Transforming Eye Care: Innovating New Glaucoma and Dry Eye Disease Treatments — Featuring Pierre Simon, VP Marketing, Sight Sciences – Xtalks Life Science Podcast Ep. 149
Blogs

Glaucoma Awareness Month 2024: New and Promising Treatments for Glaucoma
Approvals News

iDose TR Is a New Injectable Glaucoma Treatment Approved by FDA

Endpoints for Neuroprotection in Glaucoma Trials

December 08, 2023
Blogs

Interview with Thea Pharma’s Susan Benton about Innovations in Eye Care and the FDA Approval of Iyuzeh – Xtalks Life Science Podcast Ep. 94
Approvals News

Iyuzeh Approved for Reduction of Elevated Intraocular Pressure for Patients with Open-Angle Glaucoma or Ocular Hypertension
Life Science Podcast

Interview with Eye Health Biotech Santen Pharmaceuticals’ CMO Peter Sallstig – Xtalks Life Science Podcast Ep. 85
Approvals News

Omlonti Granted FDA Approval in Glaucoma and Ocular Hypertension
Diagnostics News

How Everyday Contact Lenses Could Help Monitor Ocular Disease
Approvals News

FDA Approves Biodegradable Implants for Patients with Glaucoma
Life Science News

Precision Eyedropper to Reduce Waste and Negative Side Effects of Eye Medications